Thought Leadership
Email Page
Federal Circuit to Decide Limits on Functional Claiming of Isolated Monoclonal Antibodies
October 22, 2020
Jonathan Harris, Drew Hillier, and Ali Ahmed
Biosimilar Development

Axinn partner Jonathan Harris and associate Drew Hillier authored the Biosimilar Development article, "Federal Circuit to Decide Limits on Functional Claiming of Isolated Monoclonal Antibodies." Ali Ahmed of Fresenius Kabi USA was also a co-author. 

Click here to access the article.